Status:
UNKNOWN
Multiparametric Protocol for Assessment of Intraprocedural Result of MITRACLIP Procedure
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Residual Mitral Regurgitation
Eligibility:
All Genders
18-99 years
Brief Summary
Quantification of residual mitral regurgitation (MR) after MitraClip may be challenging. Quantitative methods for severity assessment may be inaccurate and recent recommendations suggest an assessment...
Eligibility Criteria
Inclusion
- Patients with either degenerative or functional, severe or moderate to severe mitral regurgitation (MR) undergoing percutaneous edge-to-edge repair at San Raffaele Hospital from April 2019.
Exclusion
- None
Key Trial Info
Start Date :
April 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06184789
Start Date
April 27 2020
End Date
December 31 2025
Last Update
December 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCSS San Raffaele
Milan, Italy